Amylyx Pharmaceuticals Reports Third Quarter 2025 Financial Results

Go back to Amylyx Pharmaceuticals Reports Third Quarter 2025 Financial Results
(NASDAQ: AMLX) Delayed: 39.14 +0.54 (1.40%)
Previous Close $38.60    52 Week High
Open $37.49    52 Week Low
Day High $39.93    P/E N/A 
Day Low $37.37    EPS
Volume 2,072,553